Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05934994

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions Whose Malignant Origin Cannot be Excluded on Conventional Imaging

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of the study is that non-invasive Single photon emission computed tomography (SPECT-CT) bone scintigraphy makes it possible to better characterize solitary bone lesions, in particular the exclusion of their malignancy in order to avoid unnecessary biopsy and possible complications for the patient.

Detailed description

Bone scintigraphy includes 3 stages: study of perfusion then of early tissue uptake and finally of late bone fixation. Hyperactivity of malignant bone lesions at the 3 stages of bone scintigraphy has been reported, but on planar scintigraphic images not allowing precise anatomical localization of the lesions. Currently, the generalization of SPECT-CT (Single Photon Emission Computed Tomography) combined with Tomodensitometry) acquisition thanks to the deployment of semiconductor cameras, makes it possible to carry out a multiparametric analysis of bone lesions with quantification of the intensity of the signal expressed in SUVmax (Standard Uptake Value maximum) at the 3 times of the scintigraphy

Conditions

Interventions

TypeNameDescription
OTHERBone scanthe bone scintigraphy will include 3 stages: study of perfusion then early tissue uptake and finally late bone fixation

Timeline

Start date
2023-09-11
Primary completion
2025-12-10
Completion
2027-01-10
First posted
2023-07-07
Last updated
2025-01-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05934994. Inclusion in this directory is not an endorsement.